HOME >> BIOLOGY >> NEWS
Viruses may be environmentally friendly decontaminants

BALTIMORE, MD March 8, 2004 --Viruses could become the next generation of environmentally friendly decontaminants, replacing harmful chemicals like chlorine dioxide in cleaning up areas exposed to anthrax spores, according to findings released today at the American Society for Microbiology's Biodefense Research Meeting. Researchers from the Biological Defense Research Directorate in Rockville, Maryland, the Defense Science Technology Laboratory in the United Kingdom, and the University of Maryland Biotechnology Institute presented their findings.

"Decontamination modalities for anthrax to date have centered on the use of toxic biocides (formaldehyde, chlorine dioxide) or gamma radiation. These approaches suffer from the dual handicap of toxicity to man and the environment and/or are extremely expensive," says Leslie Baillie, one of the scientists on the study. "There is an urgent need for strategies which are environmentally friendly, can be used to decontaminate a range of environments with little or no toxicity to fauna and flora and are cost effective."

In the study the researchers investigated the feasibility of using lytic bacteriophage, viruses that specifically target and kill bacteria, to reduce the level of spores made by the bacteria Bacillus thuringiensis a close but harmless relative of the organism that causes anthrax. Treatment of the soil with bacteriophage resulted in a significant reduction in spore contamination.

"This study demonstrates the feasibility of decontaminating soil containing spores of a B. thuringiensis, a close relative of B. anthracis, by the co-administration of lytic bacteriophage and spore germinants. Given the toxicity of standard decontamination regimens for B. anthracis, this approach represents an environmentally friendly, cost effective alternative," says Baillie.


'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
8-Mar-2004


Page: 1

Related biology news :

1. Viruses clear bacterial contamination in chickens
2. The Virus-Cancer Link: Examining the Role of Viruses in the Development of Cancer
3. Viruses help strep bacteria turn deadly
4. Viruses concentrate
5. American Red Cross Launches New Genetic Screening Technology To Directly Detect Viruses
6. Viral Harpoon Structure Suggests Measles, HIV And Ebola Viruses Related
7. Antibody Revolution Targets STDs, Stomach Viruses, Common Cold
8. Cellular Target Of Leprosy, Deadly Viruses Found
9. New Evidence Shows How Some Flu Viruses Become Lethal
10. University of Florida Researchers Develop Filter Coating That Traps Bacteria and Viruses
11. Inter-Element Recombination Between Retrotransposons May Be Strategy For Evolution Of Viruses Like HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... ... In the wake of the success of IBBL’s international ... was launched in July 2018, in an agreement between IBBL, the International Society ... Association (BBCMBA). The one-year pilot programme offered two testing schemes: ‘DNA quantification and ...
(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected G-CON Manufacturing, ... facility. The new facility, which will anchor the VelocityTX innovation center in San ... manufacturing capabilities to support clinical cell therapy trials. GenCure is a subsidiary of ...
(Date:3/26/2019)... ... March 26, 2019 , ... ... introduce the four recipients of the Society's 2019 Outstanding Achievement Award, Outstanding New ... will be presented at the ASGCT 22nd Annual Meeting . , Outstanding ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... ... April 10, 2019 , ... ... locked into multiple agreements to help companies advance their innovations to clinical ... ranging from synthetic biology companies that are gene editing therapeutic cells for ...
(Date:4/9/2019)... ... , ... Sonny Bar Lisa, or Sonny for short, is a quarter horse ... a series of diagnostics, an MRI was performed which revealed Sonny had torn his ... found that VetStem Regenerative Cell Therapy may be a treatment option for ...
(Date:4/8/2019)... SAN FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... to accredited investors a $15 million preferred equity investment in the privately held pharmaceutical ... dysfunction. Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and ...
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive ... dialogue, today announces its Boston CEO conference to be held May 28-29, 2019 ... and opportunities with high-level panels and discussions from past, present and future change-makers. ...
Breaking Biology Technology:
Cached News: